Bestzyme Opens Automated Sweet Protein Production Line in China

Synthetic biology firm Bestzyme, a subsidiary of GenScript Biotech, has announced the completion of the world's first dedicated, automated smart production line for sweet proteins at its facility in Jinan, China. This development is intended to streamline and scale up the commercial manufacturing of these protein-based sweeteners.

The company stated that the new production line is designed to enhance manufacturing efficiency and ensure a higher, more consistent product quality. Sweet proteins are gaining attention as potential alternatives to sugar and artificial sweeteners, particularly within the food and beverage industry.

Bestzyme's investment reflects a growing market interest in natural and healthier food ingredients. While the company has not disclosed specific production capacity figures or timelines for full-scale output, the initiative signals a significant commitment to advancing sweet protein technology.

This move positions Bestzyme to capitalize on the demand for novel sweetening solutions. The increased production capabilities could foster greater competition and innovation in the market for food additives and ingredients.